Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
Basic
5
Ṁ152Jan 1
36%
chance
1D
1W
1M
ALL
The reporting must be within 2024, so if the reporting happens in January 2025 regarding Q4 2024, then this still resolves NO.
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
What fraction of US adults will regularly take GLP-1 drugs in 2030?
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
75% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
84% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
30% chance
Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
38% chance
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
12% chance
More than 10% of US citizens will be on prescription drugs for weight loss by 2031
61% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
38% chance